T89. PHARMACOGENETIC TESTING TO GUIDE ANTIPSYCHOTIC TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS
Noushin Saadullah Khani(Mental Health Research UK), Elvira Bramon(King's College London), Manuel Franco(Instituto de Investigación Biomédica de Salamanca), Barbara Barrett(King's College London), Alvin Richards‐Belle(University College London), Gesche Jűrgens(Frederiksberg Hospital), Benjamin Skov Kaas‐Hansen(Copenhagen University Hospital), Georgie Hudson(Mental Health Research UK), Georgina Mills(Mental Health Research UK), Marius Cotic(Great Ormond Street Hospital), Lorena Carrascal-Laso(Instituto de Investigación Biomédica de Salamanca), Rosemary Abidoph(Mental Health Research UK), Huajie Jin(King's College London), Soumita Ramesh(Mental Health Research UK), Lauren Varney(University College London)
Cited by 0
Related Papers
Large recurrent microdeletions associated with schizophrenia
|Nature|2008|1.8k
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
|Nature Genetics|2010|1.1k
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
|Nature Genetics|2011|917
Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial
|The Lancet|2016|599
Disruption of the neurexin 1 gene is associated with schizophrenia
|Human Molecular Genetics|2008|485